with CE-IVD certification recognised for facilitating registration in several non-European countries. Approximately 30% of individuals, and up to 56% in certain ethnic groups, carry DNA variants ...

SeekIn has announced the clinical validation of its SeekInCare blood test, intended for the early identification of various ...

A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare®, a novel, non-invasive multi-omics blood test designed for the early ...

Illumina Inc. today announced an expanded clinical oncology portfolio, unlocking the next new solutions to advance precision oncology and improve the standard of care. The company's broad range of ...

As Oregon’s catcher, Emma Cox knows All-American Lyndsey Grein throws lots of filthy pitches. Grein outdid herself Friday at ...

Japan approves ILMN's TSO Comprehensive, marking a key step forward in global precision oncology adoption and clinical use.

Outside of Phoenix in suburban Gilbert, one farming family decided over 10 years ago to get ahead of development and urban ...

The assay is intended to help with assessing HIV viral load levels that are used to monitor effectiveness of antiretroviral treatment.

Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows Revvity, Inc. (NYSE ...